Patent and Trademark Office

HealthVerity Awarded U.S. Patent for Privacy-Preserving Analysis for Secure Multi-Party Computing

Retrieved on: 
Wednesday, December 9, 2020

PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ --HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat.

Key Points: 
  • PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ --HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat.
  • 10,824,738 on November 3, 2020 in support of HealthVerity's privacy-preserving technology that enables analysis and correlation of disparate datasets for cohorts of interest while preserving individual privacy.
  • "Traditional research has been hindered by the inability to link healthcare data with social determinants of health in a HIPAA-compliant manner," said Andrew Kress, CEO of HealthVerity.
  • This patent is the latest award by the USPTO to HealthVerity in the area of privacy preservation, preceded by U.S. Pat.

Ford Honors Schaeffler at the 22nd Annual World Excellence Awards

Retrieved on: 
Tuesday, November 17, 2020

FORT MILL, S.C., Nov. 17, 2020 /PRNewswire/ -- Schaeffler was recognized as a top-performing global supplier at the 22nd annual Ford World Excellence Awards.

Key Points: 
  • FORT MILL, S.C., Nov. 17, 2020 /PRNewswire/ -- Schaeffler was recognized as a top-performing global supplier at the 22nd annual Ford World Excellence Awards.
  • Schaeffler was announced as a "Brand Pillar: Propulsion Choices" winner during Ford Motor Company's virtual event on Oct. 30, 2020.
  • "Ford's annual World Excellence Awards recognize our top-performing suppliers for their contributions to our success," said Hau Thai-Tang, chief product platform and operations officer.
  • Moreover, with almost 2,400 patent applications in 2019, Schaeffler is Germany's second-most innovative company according to the German Patent and Trademark Office (DPMA).

Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications

Retrieved on: 
Thursday, November 12, 2020

Provisional Patent applications with the U.S. Patent and Trademark Office ("USPTO") pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin.

Key Points: 
  • Provisional Patent applications with the U.S. Patent and Trademark Office ("USPTO") pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin.
  • Each of these provisional patents relates to the continued research and development of the central nervous system-homing peptides covered by the UMD option agreement to deliver certain compounds, stated Eric Weisblum, Chairman and CEO of Silo Pharma.
  • We are excited to have taken this important action with respect to our recently announced collaboration with UMD.
  • A provisional patent application is a critical step on the road to commercial viability.

edatanetworks Inc. Receives Additional Click2Sale Digital Advertising Patent from USTPO

Retrieved on: 
Wednesday, November 4, 2020

EDMONTON, AB, Nov. 4, 2020 /PRNewswire/ - edatanetworks Inc. announced today the approval of a digital advertising patent from the United States Patent and Trademark Office (USPTO).

Key Points: 
  • EDMONTON, AB, Nov. 4, 2020 /PRNewswire/ - edatanetworks Inc. announced today the approval of a digital advertising patent from the United States Patent and Trademark Office (USPTO).
  • edatanetworks' intellectual property rights and portfolio continue to expand with the allowance from the USPTO of patent 14/480,721.
  • This key patent further protects the fundamental methods in measuring online to offline digital commerce and its effectiveness in the advertising space, utilizing connections already in place today with online and offline advertisers, financial institutions, payment networks, merchants, consumers, and communities.
  • "This significant patent closes the loop with online interactions to offline purchases through digital advertising.

Yellowdig Receives Patent for Gamification Technology

Retrieved on: 
Tuesday, October 20, 2020

PHILADELPHIA, Oct. 20, 2020 /PRNewswire-PRWeb/ --The signature gamification features that make Yellowdig the best online learning tool have received a patent from the United States Patent and Trademark Office.

Key Points: 
  • PHILADELPHIA, Oct. 20, 2020 /PRNewswire-PRWeb/ --The signature gamification features that make Yellowdig the best online learning tool have received a patent from the United States Patent and Trademark Office.
  • The specific element covered in this patent is Yellowdig's prediction and alert system that identifies students who are at risk of dropping out.
  • Universities and other partners have already had immense success in improving retention rates as a result of using Yellowdig's software.
  • According to the founder and CEO, Shaunak Roy, "When I founded Yellowdig with a mission to enable community based learning in our classrooms, I naturally gravitated towards incorporating gamification in the platform.

U.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis

Retrieved on: 
Friday, October 16, 2020

Renew Biopharma today announced that the United States Patent and Trademark Office (USPTO) has granted powerful patent claims on the landmark patent application (WO2019183152) relating to the rational-based engineering of a key enzyme that is most efficient for large-scale microbial cannabinoid biosynthesis (i.e.

Key Points: 
  • Renew Biopharma today announced that the United States Patent and Trademark Office (USPTO) has granted powerful patent claims on the landmark patent application (WO2019183152) relating to the rational-based engineering of a key enzyme that is most efficient for large-scale microbial cannabinoid biosynthesis (i.e.
  • While some biosynthesis companies have employed different (prenyltransferase) enzymes derived from the Cannabis plant, these plant-derived enzymes are suboptimal for microbial production.
  • The newly granted patent claims provide exclusive rights to employ the best-known, non-natural amino acid substitutions to NphB.
  • Renew Biopharma ( www.RenewBiopharma.com ), a startup biotech company based in San Diego, is focused on creating therapeutics for neuroinflammatory diseases.

Schaeffler Introduces CONCEPT1™ Single-Point Automatic Lubricator

Retrieved on: 
Thursday, October 15, 2020

FORT MILL, S.C., Oct. 15, 2020 /PRNewswire/ -- Global industrial and automotive supplier Schaeffler is launching its innovative CONCEPT1 single-point automatic lubricator to the North American market.

Key Points: 
  • FORT MILL, S.C., Oct. 15, 2020 /PRNewswire/ -- Global industrial and automotive supplier Schaeffler is launching its innovative CONCEPT1 single-point automatic lubricator to the North American market.
  • Schaeffler's CONCEPT1 single-point lubricator uses an electrochemical reaction to precisely and continuously supply the proper amount of lubricant to rolling bearings inside electric motors and other industrial machinery.
  • CONCEPT1 is available pre-filled with Schaeffler's industry-leading line of Arcanol greases, or customers can have CONCEPT1 filled at the factory with an extensive selection of name-brand and special-order lubricants.
  • With just under 2,400 patent applications in 2019, Schaeffler is Germany's second-most innovative company according to the German Patent and Trademark Office (DPMA).

SentinelOne Secures Patent for Breakthrough Protection Techniques

Retrieved on: 
Thursday, October 15, 2020

SentinelOne , the autonomous cybersecurity platform company, today announced it has secured a new patent from the U.S. Patent & Trademark Office ( USPTO ).

Key Points: 
  • SentinelOne , the autonomous cybersecurity platform company, today announced it has secured a new patent from the U.S. Patent & Trademark Office ( USPTO ).
  • The patent is a testament to SentinelOnes innovative XDR platform and underlying technology innovation.
  • Most enterprises today are tasked with defending a dissolving perimeter in a complex threat environment, which means that endpoint protection solutions must be comprehensive, said Shlomi Salem, AVP, Security Research, SentinelOne.
  • The patent is a combination of three separate SentinelOne innovations -- automatic feature extractor, code detector, and position-independent code detection -- that significantly enhance the XDR platforms detection capabilities.

Canon U.S.A. Helps Bridge the Document Workflow Divide between the Corporate Office and the Home Office

Retrieved on: 
Thursday, September 17, 2020

Due to their small footprint, rich feature set, competitive price points, and tight integration with certain Canon office solutions, these models are designed for users in a variety of work environments, such as the corporate office, the home office, or a combination of both.

Key Points: 
  • Due to their small footprint, rich feature set, competitive price points, and tight integration with certain Canon office solutions, these models are designed for users in a variety of work environments, such as the corporate office, the home office, or a combination of both.
  • The end resulta print and scan infrastructure that's flexible, incorporates security features, and is built for today's work environment.
  • Both imageCLASS X and imageRUNNER ADVANCE DX models support the Canon PRINT Business app*, allowing users to perform many functions simply and conveniently from their compatible smartphone.
  • Based on weekly patent counts issued by United States Patent and Trademark Office.

Galenagen Receives Patent for Remote Monitoring of Parkinson's Disease

Retrieved on: 
Wednesday, September 16, 2020

RYE BROOK, N.Y., Sept. 16, 2020 /PRNewswire/ --Galenagen, LLC, announced todaythat the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Key Points: 
  • RYE BROOK, N.Y., Sept. 16, 2020 /PRNewswire/ --Galenagen, LLC, announced todaythat the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 10,776,453 relating to remote monitoring of Parkinson's Disease.
  • Galenagen's patent is directed to methods of employing remote data gathering and monitoring for diagnosing, staging and treatment of Parkinson's Disease, movement and neurological disorders and chronic pain.
  • The technology will help facilitate early Parkinson's staging and ongoing monitoring of a patient's condition.